Skip to main content
PMC home page
The Journal of Headache and Pain logoLink to The Journal of Headache and Pain
. 2007 Sep 24;8(4):236–241. doi: 10.1007/s10194-007-0400-0

Botulinum toxin type-A therapy in cluster headache: an open study

Petra Sostak 1,✉, Phillip Krause 1, Stefanie Förderreuther 1, Veronika Reinisch 1, Andreas Straube 1
PMCID: PMC3451674  PMID: 17901920

Abstract

The objective of this open single-centre study was to evaluate the efficacy and tolerability of botulinum toxin type-A (BTX-A) as add-on in the prophylactic treatment of cluster headache (CH). Twelve male patients with episodic (n=3) or chronic (n=9) CH, unresponsive to common prophylactic medications, were treated with a cumulative dose of 50 International Units (IU) BTX-A according to a standardised injection scheme into the ipsilateral pericranial muscles. One patient with chronic CH experienced a total cessation of attacks and in 2 patients attack intensity and frequency improved. In another patient with chronic CH typical attacks were not influenced, but an ipsilateral continuous occipital headache significantly improved. Patients with episodic CH did not benefit from BTX-A treatment. Tolerability was excellent. These findings provide evidence that BTX-A may be beneficial as an add-on prophylactic therapy for a limited number of patients with chronic CH.

Keywords: Cluster headache, Botulinum toxin-A, Headache/drug therapy, Treatment outcome

Full Text

The Full Text of this article is available as a PDF (71.1 KB).

References

  • 1.Russel M.B. Epidemiology and genetics of cluster headache. Lancet Neurol. 2004;3:279–283. doi: 10.1016/S1474-4422(04)00735-5. [DOI] [PubMed] [Google Scholar]
  • 2.Favier I., Haan J. Chronic cluster headache: a review. J Headache Pain. 2005;6:3–9. doi: 10.1007/s10194-005-0142-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rosales R.L., Arimura K., Takenaga S., Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve. 1996;19:488–496. doi: 10.1002/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  • 4.Silberstein S., Mathew N., Saper J., Jenkins S. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache. 2000;40:445–450. doi: 10.1046/j.1526-4610.2000.00066.x. [DOI] [PubMed] [Google Scholar]
  • 5.Brin M.F., Swope D.M., o’Brian C., et al. Botox for migraine: doubleblind, placebo-controlled, region-specific evaluation. Cephalalgia. 2000;20:421–422. doi: 10.1046/j.1468-2982.2000.020004421.x. [DOI] [Google Scholar]
  • 6.Mathew N.T., Frishberg B.M., Gawel M., et al. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache. 2005;45:293–307. doi: 10.1111/j.1526-4610.2005.05066.x. [DOI] [PubMed] [Google Scholar]
  • 7.Farinelli I., Coloprisco G., Filippis S., Martelletti P. Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience. J Headache Pain. 2006;7:407–412. doi: 10.1007/s10194-006-0344-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Porta M., Camerlingo M. Headache and botulinum toxin. J Headache Pain. 2005;6:325–327. doi: 10.1007/s10194-005-0222-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Goadsby P.J., Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33:48–56. doi: 10.1002/ana.410330109. [DOI] [PubMed] [Google Scholar]
  • 10.Freund B.J., Schwartz M. The use of Botulinum toxin-A in the treatment of refractory cluster headache: case reports. Cephalalgia. 2000;20:325–331. doi: 10.1046/j.1468-2982.2000.020004325.x. [DOI] [Google Scholar]
  • 11.Smuts J.A., Barnard P.W.A. Botulinum Toxin type A in the treatment of headache syndromes: a clinical report on 79 patients. Cephalalgia. 2000;20:332. doi: 10.1046/j.1468-2982.2000.020004332.x. [DOI] [Google Scholar]
  • 12.Robbins L. Botulinum Toxin A (Botox) for cluster headache: 6 cases. Cephalalgia. 2001;21:499–500. [Google Scholar]
  • 13.The International Classification of Headache Disorders, 2nd edn. Headache Classification Subcommittee of the International Headache Society (2004) Cephalalgia 24:44–48
  • 14.Solomon S., Lipton R.B., Newman L.C. Nuchal features of cluster headache. Headache. 1990;30:347–349. doi: 10.1111/j.1526-4610.1990.hed3006347.x. [DOI] [PubMed] [Google Scholar]
  • 15.Verslegers W.R., Pickut B.A., Deyn P.P. Paroxysmal neuralgic upper cervical pain attacks: The lower syndrome of cluster headache. Clin Neurol Neurosurg. 2006;108:737–743. doi: 10.1016/j.clineuro.2006.03.001. [DOI] [PubMed] [Google Scholar]
  • 16.Hardebo J.E. How cluster headache is explained as an intracavernous inflammatory process lesioning sympathetic fibers. Headache. 1994;34:125–131. doi: 10.1111/j.1526-4610.1994.hed3403125.x. [DOI] [PubMed] [Google Scholar]
  • 17.Sprenger T., Valet M., Hammes M., et al. Hypothalamic activation in trigeminal autonomic cephalgia: functional imaging of an atypical case. Cephalalgia. 2004;24:753–757. doi: 10.1111/j.1468-2982.2004.00753.x. [DOI] [PubMed] [Google Scholar]
  • 18.May A., Bahra A., Buchel C., et al. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352:275–278. doi: 10.1016/S0140-6736(98)02470-2. [DOI] [PubMed] [Google Scholar]
  • 19.May A., Ashburner J., Buchel C., et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med. 1999;5:836–838. doi: 10.1038/10561. [DOI] [PubMed] [Google Scholar]
  • 20.Franzini A., Ferroli P., Leone M., Broggi G. Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery. 2003;52:1095–1099. doi: 10.1227/01.NEU.0000057698.29634.D6. [DOI] [PubMed] [Google Scholar]
  • 21.Leone M., Franzini A., Broggi G., Bussone G. Hypothalamic deep brain stimulation for intractable chronic cluster headache: a 3-year follow-up. Neurol Sci. 2003;24(Suppl2):S143–145. doi: 10.1007/s100720300063. [DOI] [PubMed] [Google Scholar]
  • 22.Schoenen J., Clemente L., Vandenheede M., et al. Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain. 2005;128:940–947. doi: 10.1093/brain/awh411. [DOI] [PubMed] [Google Scholar]
  • 23.Malick A., Strassman R.M., Burstein R. Trigeminohypothalamic and reticulohypothalamic tract neurons in the upper cervical spinal cord and caudal medulla of the rat. J Neurophysiol. 2000;84:2078–2112. doi: 10.1152/jn.2000.84.4.2078. [DOI] [PubMed] [Google Scholar]
  • 24.Aoki K.R. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. NeuroToxicology. 2005;26:785–793. doi: 10.1016/j.neuro.2005.01.017. [DOI] [PubMed] [Google Scholar]
  • 25.Wiegand H., Erdmann G., Wellhoner H.H. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol. 1976;292:161–165. doi: 10.1007/BF00498587. [DOI] [PubMed] [Google Scholar]
  • 26.Welch M.J., Purkiss J.R., Foster K.A. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon. 2000;38:245–258. doi: 10.1016/S0041-0101(99)00153-1. [DOI] [PubMed] [Google Scholar]
  • 27.Durham P.L., Cady R. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache. 2004;44:35–42. doi: 10.1111/j.1526-4610.2004.04007.x. [DOI] [PubMed] [Google Scholar]
  • 28.Nilsson Remal A.I.M., Laudon Meyer E., Cordonnier C., Goadsby P.J. Placebo response in cluster headache trials: a review. Cephalalgia. 2003;23:504–510. doi: 10.1046/j.1468-2982.2003.00531.x. [DOI] [PubMed] [Google Scholar]
  • 29.Monstad I., Krabbe A., Micieli G., et al. Preemptive oral treatment with sumatriptan during a cluster period. Headache. 1995;35:607–613. doi: 10.1111/j.1526-4610.1995.hed3510607.x. [DOI] [PubMed] [Google Scholar]
  • 30.Steiner T.J., Hering R., Couturier E.G.M., et al. Double-blind placebo-controlled trial of lithium in episodic cluster headache. Cephalalgia. 1997;17:673–675. doi: 10.1046/j.1468-2982.1997.1706673.x. [DOI] [PubMed] [Google Scholar]
  • 31.Nilsson Remahl A.I., Ansjon R., Lind F., Waldenlind E. Hyperbaric oxygen treatment of active cluster headache: a double blind placebo-controlled cross-over study. Cephalalgia. 2002;22:730–739. doi: 10.1046/j.1468-2982.2002.00450.x. [DOI] [PubMed] [Google Scholar]
  • 32.Cittadini E., May A., Straube A., et al. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol. 2006;63:1537–1542. doi: 10.1001/archneur.63.11.nct60002. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Headache and Pain are provided here courtesy of BMC

RESOURCES